Cancer Management and Research-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2211106, encodeId=3703221110668, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;慢病管理;肿瘤康复 经验分享：2023年度影响因子为2.5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:55:20 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2201206, encodeId=fdb722012064c, content=真的好慢啊，反复要原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d8514465, createdName=ms1000001446944017, createdTime=Tue Apr 30 10:08:27 CST 2024, time=2024-04-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2174772, encodeId=7da221e4772f9, content=记录一下： 23.11.27投稿 1A; 11.30 1ab; 12.02 1e; 12.06 收到邮件解释动物伦理问题并上传伦理批件； 12.08 1f; 12.11 又变成1e，收到邮件说提供WB原始图； 12.12 1f; 12.13 2a , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Wed Dec 13 18:07:24 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197766, encodeId=bca8219e766bf, content=跟共同作者联系不方便的慎投，经常要给每个作者发邮件，需要每个作者确认。而且3周了还在初审，找审稿人也巨慢，投另一个杂志ONCOtarget and therapy的时候经过一个半月没找到审稿人退回了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed Apr 10 15:59:10 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192990, encodeId=39982192990c9, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/47914c6997134a928ed954f7a8071140-N1SdjCB9k2Cx.jpg, createdBy=0fcc9212232, createdName=weichusci01, createdTime=Wed Mar 13 16:46:07 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1062688, encodeId=4040106268899, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2750.0 偏重的研究方向：肿瘤学;淋巴瘤 经验分享：投稿时间：18/Aug/2021 审稿返回：2021.9.13 接受：2021.10.15 On-line出版时间：21/Oct/2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8e32007663, createdName=Doctor Xu, createdTime=Thu Oct 21 20:20:00 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568257, encodeId=250856825e05, content=我的文章是用了一个多月的时间才找到审稿人。但是审稿速度很快，两周内意见就回来了？xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, beContent=xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab612479180, createdName=124544f0m58暂无昵称, createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161461, encodeId=c79f2161461d2, content=有1a持续16天还没消息的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Sun Oct 08 08:24:57 CST 2023, time=2023-10-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1243270, encodeId=668012432e0a6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;肝纤维化 经验分享：2022.1.26投稿，2022.1.31上传伦理，2022.2.3 1F，2022.2.8 1e，2022.2.9 1F，2022.2.9 2A，2022.2.27 2B，2022.3.10 2C，2022.3.21 2d，2022.3.29 2E，2022.3.30 2G，2022.4.11 3B，2022.4.19 4a，2022.8.18 4b, 2022.9.1 4C, 2022.9.4 5AB, 2022.9.5 5B。中间返修补实验的时间比较多，又碰上疫情反复，延长了2次返修时间，编辑人很好，返修回去后编辑因为一些文本问题多次让我修改，改到第4版才符合编辑要求；虽说中科院预警，但审稿人的意见还是很中肯，一个审稿人提了9个问题，另一个审稿人提了4个问题，4个问题短小精悍，对提升文章质量还是有用的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad485077980, createdName=炼铁手, createdTime=Mon Sep 05 10:03:24 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126145, encodeId=e5e1212614526, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：是被踢出SCI了吗？文章逐年减少，4月了，现在文章才有32篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Sat Apr 15 22:41:13 CST 2023, time=2023-04-15, status=1, ipAttribution=浙江省)]

2024-06-22 侠胆医心来自威斯康星

审稿速度:6.0 | 投稿命中率:95.0
偏重的研究方向：肿瘤;慢病管理;肿瘤康复
经验分享：2023年度影响因子为2.5分

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2211106, encodeId=3703221110668, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;慢病管理;肿瘤康复 经验分享：2023年度影响因子为2.5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:55:20 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2201206, encodeId=fdb722012064c, content=真的好慢啊，反复要原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d8514465, createdName=ms1000001446944017, createdTime=Tue Apr 30 10:08:27 CST 2024, time=2024-04-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2174772, encodeId=7da221e4772f9, content=记录一下： 23.11.27投稿 1A; 11.30 1ab; 12.02 1e; 12.06 收到邮件解释动物伦理问题并上传伦理批件； 12.08 1f; 12.11 又变成1e，收到邮件说提供WB原始图； 12.12 1f; 12.13 2a , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Wed Dec 13 18:07:24 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197766, encodeId=bca8219e766bf, content=跟共同作者联系不方便的慎投，经常要给每个作者发邮件，需要每个作者确认。而且3周了还在初审，找审稿人也巨慢，投另一个杂志ONCOtarget and therapy的时候经过一个半月没找到审稿人退回了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed Apr 10 15:59:10 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192990, encodeId=39982192990c9, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/47914c6997134a928ed954f7a8071140-N1SdjCB9k2Cx.jpg, createdBy=0fcc9212232, createdName=weichusci01, createdTime=Wed Mar 13 16:46:07 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1062688, encodeId=4040106268899, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2750.0 偏重的研究方向：肿瘤学;淋巴瘤 经验分享：投稿时间：18/Aug/2021 审稿返回：2021.9.13 接受：2021.10.15 On-line出版时间：21/Oct/2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8e32007663, createdName=Doctor Xu, createdTime=Thu Oct 21 20:20:00 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568257, encodeId=250856825e05, content=我的文章是用了一个多月的时间才找到审稿人。但是审稿速度很快，两周内意见就回来了？xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, beContent=xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab612479180, createdName=124544f0m58暂无昵称, createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161461, encodeId=c79f2161461d2, content=有1a持续16天还没消息的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Sun Oct 08 08:24:57 CST 2023, time=2023-10-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1243270, encodeId=668012432e0a6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;肝纤维化 经验分享：2022.1.26投稿，2022.1.31上传伦理，2022.2.3 1F，2022.2.8 1e，2022.2.9 1F，2022.2.9 2A，2022.2.27 2B，2022.3.10 2C，2022.3.21 2d，2022.3.29 2E，2022.3.30 2G，2022.4.11 3B，2022.4.19 4a，2022.8.18 4b, 2022.9.1 4C, 2022.9.4 5AB, 2022.9.5 5B。中间返修补实验的时间比较多，又碰上疫情反复，延长了2次返修时间，编辑人很好，返修回去后编辑因为一些文本问题多次让我修改，改到第4版才符合编辑要求；虽说中科院预警，但审稿人的意见还是很中肯，一个审稿人提了9个问题，另一个审稿人提了4个问题，4个问题短小精悍，对提升文章质量还是有用的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad485077980, createdName=炼铁手, createdTime=Mon Sep 05 10:03:24 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126145, encodeId=e5e1212614526, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：是被踢出SCI了吗？文章逐年减少，4月了，现在文章才有32篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Sat Apr 15 22:41:13 CST 2023, time=2023-04-15, status=1, ipAttribution=浙江省)]

2024-04-30 ms1000001446944017 来自山东省

真的好慢啊，反复要原始数据

38 0

[GetPortalCommentsPageByObjectIdResponse(id=2211106, encodeId=3703221110668, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;慢病管理;肿瘤康复 经验分享：2023年度影响因子为2.5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:55:20 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2201206, encodeId=fdb722012064c, content=真的好慢啊，反复要原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d8514465, createdName=ms1000001446944017, createdTime=Tue Apr 30 10:08:27 CST 2024, time=2024-04-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2174772, encodeId=7da221e4772f9, content=记录一下： 23.11.27投稿 1A; 11.30 1ab; 12.02 1e; 12.06 收到邮件解释动物伦理问题并上传伦理批件； 12.08 1f; 12.11 又变成1e，收到邮件说提供WB原始图； 12.12 1f; 12.13 2a , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Wed Dec 13 18:07:24 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197766, encodeId=bca8219e766bf, content=跟共同作者联系不方便的慎投，经常要给每个作者发邮件，需要每个作者确认。而且3周了还在初审，找审稿人也巨慢，投另一个杂志ONCOtarget and therapy的时候经过一个半月没找到审稿人退回了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed Apr 10 15:59:10 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192990, encodeId=39982192990c9, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/47914c6997134a928ed954f7a8071140-N1SdjCB9k2Cx.jpg, createdBy=0fcc9212232, createdName=weichusci01, createdTime=Wed Mar 13 16:46:07 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1062688, encodeId=4040106268899, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2750.0 偏重的研究方向：肿瘤学;淋巴瘤 经验分享：投稿时间：18/Aug/2021 审稿返回：2021.9.13 接受：2021.10.15 On-line出版时间：21/Oct/2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8e32007663, createdName=Doctor Xu, createdTime=Thu Oct 21 20:20:00 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568257, encodeId=250856825e05, content=我的文章是用了一个多月的时间才找到审稿人。但是审稿速度很快，两周内意见就回来了？xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, beContent=xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab612479180, createdName=124544f0m58暂无昵称, createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161461, encodeId=c79f2161461d2, content=有1a持续16天还没消息的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Sun Oct 08 08:24:57 CST 2023, time=2023-10-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1243270, encodeId=668012432e0a6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;肝纤维化 经验分享：2022.1.26投稿，2022.1.31上传伦理，2022.2.3 1F，2022.2.8 1e，2022.2.9 1F，2022.2.9 2A，2022.2.27 2B，2022.3.10 2C，2022.3.21 2d，2022.3.29 2E，2022.3.30 2G，2022.4.11 3B，2022.4.19 4a，2022.8.18 4b, 2022.9.1 4C, 2022.9.4 5AB, 2022.9.5 5B。中间返修补实验的时间比较多，又碰上疫情反复，延长了2次返修时间，编辑人很好，返修回去后编辑因为一些文本问题多次让我修改，改到第4版才符合编辑要求；虽说中科院预警，但审稿人的意见还是很中肯，一个审稿人提了9个问题，另一个审稿人提了4个问题，4个问题短小精悍，对提升文章质量还是有用的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad485077980, createdName=炼铁手, createdTime=Mon Sep 05 10:03:24 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126145, encodeId=e5e1212614526, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：是被踢出SCI了吗？文章逐年减少，4月了，现在文章才有32篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Sat Apr 15 22:41:13 CST 2023, time=2023-04-15, status=1, ipAttribution=浙江省)]

2023-12-13 秋思来自广东省

记录一下：
23.11.27投稿 1A; 11.30 1ab; 12.02 1e; 12.06 收到邮件解释动物伦理问题并上传伦理批件； 12.08 1f; 12.11 又变成1e，收到邮件说提供WB原始图； 12.12 1f; 12.13 2a

83 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211106, encodeId=3703221110668, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;慢病管理;肿瘤康复 经验分享：2023年度影响因子为2.5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:55:20 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2201206, encodeId=fdb722012064c, content=真的好慢啊，反复要原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d8514465, createdName=ms1000001446944017, createdTime=Tue Apr 30 10:08:27 CST 2024, time=2024-04-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2174772, encodeId=7da221e4772f9, content=记录一下： 23.11.27投稿 1A; 11.30 1ab; 12.02 1e; 12.06 收到邮件解释动物伦理问题并上传伦理批件； 12.08 1f; 12.11 又变成1e，收到邮件说提供WB原始图； 12.12 1f; 12.13 2a , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Wed Dec 13 18:07:24 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197766, encodeId=bca8219e766bf, content=跟共同作者联系不方便的慎投，经常要给每个作者发邮件，需要每个作者确认。而且3周了还在初审，找审稿人也巨慢，投另一个杂志ONCOtarget and therapy的时候经过一个半月没找到审稿人退回了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed Apr 10 15:59:10 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192990, encodeId=39982192990c9, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/47914c6997134a928ed954f7a8071140-N1SdjCB9k2Cx.jpg, createdBy=0fcc9212232, createdName=weichusci01, createdTime=Wed Mar 13 16:46:07 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1062688, encodeId=4040106268899, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2750.0 偏重的研究方向：肿瘤学;淋巴瘤 经验分享：投稿时间：18/Aug/2021 审稿返回：2021.9.13 接受：2021.10.15 On-line出版时间：21/Oct/2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8e32007663, createdName=Doctor Xu, createdTime=Thu Oct 21 20:20:00 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568257, encodeId=250856825e05, content=我的文章是用了一个多月的时间才找到审稿人。但是审稿速度很快，两周内意见就回来了？xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, beContent=xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab612479180, createdName=124544f0m58暂无昵称, createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161461, encodeId=c79f2161461d2, content=有1a持续16天还没消息的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Sun Oct 08 08:24:57 CST 2023, time=2023-10-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1243270, encodeId=668012432e0a6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;肝纤维化 经验分享：2022.1.26投稿，2022.1.31上传伦理，2022.2.3 1F，2022.2.8 1e，2022.2.9 1F，2022.2.9 2A，2022.2.27 2B，2022.3.10 2C，2022.3.21 2d，2022.3.29 2E，2022.3.30 2G，2022.4.11 3B，2022.4.19 4a，2022.8.18 4b, 2022.9.1 4C, 2022.9.4 5AB, 2022.9.5 5B。中间返修补实验的时间比较多，又碰上疫情反复，延长了2次返修时间，编辑人很好，返修回去后编辑因为一些文本问题多次让我修改，改到第4版才符合编辑要求；虽说中科院预警，但审稿人的意见还是很中肯，一个审稿人提了9个问题，另一个审稿人提了4个问题，4个问题短小精悍，对提升文章质量还是有用的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad485077980, createdName=炼铁手, createdTime=Mon Sep 05 10:03:24 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126145, encodeId=e5e1212614526, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：是被踢出SCI了吗？文章逐年减少，4月了，现在文章才有32篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Sat Apr 15 22:41:13 CST 2023, time=2023-04-15, status=1, ipAttribution=浙江省)]

2024-04-10 ms3000000420360328 来自浙江省

跟共同作者联系不方便的慎投，经常要给每个作者发邮件，需要每个作者确认。而且3周了还在初审，找审稿人也巨慢，投另一个杂志ONCOtarget and therapy的时候经过一个半月没找到审稿人退回了。

34 0

[GetPortalCommentsPageByObjectIdResponse(id=2211106, encodeId=3703221110668, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;慢病管理;肿瘤康复 经验分享：2023年度影响因子为2.5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:55:20 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2201206, encodeId=fdb722012064c, content=真的好慢啊，反复要原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d8514465, createdName=ms1000001446944017, createdTime=Tue Apr 30 10:08:27 CST 2024, time=2024-04-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2174772, encodeId=7da221e4772f9, content=记录一下： 23.11.27投稿 1A; 11.30 1ab; 12.02 1e; 12.06 收到邮件解释动物伦理问题并上传伦理批件； 12.08 1f; 12.11 又变成1e，收到邮件说提供WB原始图； 12.12 1f; 12.13 2a , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Wed Dec 13 18:07:24 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197766, encodeId=bca8219e766bf, content=跟共同作者联系不方便的慎投，经常要给每个作者发邮件，需要每个作者确认。而且3周了还在初审，找审稿人也巨慢，投另一个杂志ONCOtarget and therapy的时候经过一个半月没找到审稿人退回了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed Apr 10 15:59:10 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192990, encodeId=39982192990c9, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/47914c6997134a928ed954f7a8071140-N1SdjCB9k2Cx.jpg, createdBy=0fcc9212232, createdName=weichusci01, createdTime=Wed Mar 13 16:46:07 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1062688, encodeId=4040106268899, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2750.0 偏重的研究方向：肿瘤学;淋巴瘤 经验分享：投稿时间：18/Aug/2021 审稿返回：2021.9.13 接受：2021.10.15 On-line出版时间：21/Oct/2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8e32007663, createdName=Doctor Xu, createdTime=Thu Oct 21 20:20:00 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568257, encodeId=250856825e05, content=我的文章是用了一个多月的时间才找到审稿人。但是审稿速度很快，两周内意见就回来了？xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, beContent=xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab612479180, createdName=124544f0m58暂无昵称, createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161461, encodeId=c79f2161461d2, content=有1a持续16天还没消息的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Sun Oct 08 08:24:57 CST 2023, time=2023-10-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1243270, encodeId=668012432e0a6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;肝纤维化 经验分享：2022.1.26投稿，2022.1.31上传伦理，2022.2.3 1F，2022.2.8 1e，2022.2.9 1F，2022.2.9 2A，2022.2.27 2B，2022.3.10 2C，2022.3.21 2d，2022.3.29 2E，2022.3.30 2G，2022.4.11 3B，2022.4.19 4a，2022.8.18 4b, 2022.9.1 4C, 2022.9.4 5AB, 2022.9.5 5B。中间返修补实验的时间比较多，又碰上疫情反复，延长了2次返修时间，编辑人很好，返修回去后编辑因为一些文本问题多次让我修改，改到第4版才符合编辑要求；虽说中科院预警，但审稿人的意见还是很中肯，一个审稿人提了9个问题，另一个审稿人提了4个问题，4个问题短小精悍，对提升文章质量还是有用的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad485077980, createdName=炼铁手, createdTime=Mon Sep 05 10:03:24 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126145, encodeId=e5e1212614526, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：是被踢出SCI了吗？文章逐年减少，4月了，现在文章才有32篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Sat Apr 15 22:41:13 CST 2023, time=2023-04-15, status=1, ipAttribution=浙江省)]

2024-03-13 weichusci01 来自广西

周期也就两三个月

42 0

[GetPortalCommentsPageByObjectIdResponse(id=2211106, encodeId=3703221110668, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;慢病管理;肿瘤康复 经验分享：2023年度影响因子为2.5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:55:20 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2201206, encodeId=fdb722012064c, content=真的好慢啊，反复要原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d8514465, createdName=ms1000001446944017, createdTime=Tue Apr 30 10:08:27 CST 2024, time=2024-04-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2174772, encodeId=7da221e4772f9, content=记录一下： 23.11.27投稿 1A; 11.30 1ab; 12.02 1e; 12.06 收到邮件解释动物伦理问题并上传伦理批件； 12.08 1f; 12.11 又变成1e，收到邮件说提供WB原始图； 12.12 1f; 12.13 2a , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Wed Dec 13 18:07:24 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197766, encodeId=bca8219e766bf, content=跟共同作者联系不方便的慎投，经常要给每个作者发邮件，需要每个作者确认。而且3周了还在初审，找审稿人也巨慢，投另一个杂志ONCOtarget and therapy的时候经过一个半月没找到审稿人退回了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed Apr 10 15:59:10 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192990, encodeId=39982192990c9, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/47914c6997134a928ed954f7a8071140-N1SdjCB9k2Cx.jpg, createdBy=0fcc9212232, createdName=weichusci01, createdTime=Wed Mar 13 16:46:07 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1062688, encodeId=4040106268899, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2750.0 偏重的研究方向：肿瘤学;淋巴瘤 经验分享：投稿时间：18/Aug/2021 审稿返回：2021.9.13 接受：2021.10.15 On-line出版时间：21/Oct/2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8e32007663, createdName=Doctor Xu, createdTime=Thu Oct 21 20:20:00 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568257, encodeId=250856825e05, content=我的文章是用了一个多月的时间才找到审稿人。但是审稿速度很快，两周内意见就回来了？xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, beContent=xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab612479180, createdName=124544f0m58暂无昵称, createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161461, encodeId=c79f2161461d2, content=有1a持续16天还没消息的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Sun Oct 08 08:24:57 CST 2023, time=2023-10-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1243270, encodeId=668012432e0a6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;肝纤维化 经验分享：2022.1.26投稿，2022.1.31上传伦理，2022.2.3 1F，2022.2.8 1e，2022.2.9 1F，2022.2.9 2A，2022.2.27 2B，2022.3.10 2C，2022.3.21 2d，2022.3.29 2E，2022.3.30 2G，2022.4.11 3B，2022.4.19 4a，2022.8.18 4b, 2022.9.1 4C, 2022.9.4 5AB, 2022.9.5 5B。中间返修补实验的时间比较多，又碰上疫情反复，延长了2次返修时间，编辑人很好，返修回去后编辑因为一些文本问题多次让我修改，改到第4版才符合编辑要求；虽说中科院预警，但审稿人的意见还是很中肯，一个审稿人提了9个问题，另一个审稿人提了4个问题，4个问题短小精悍，对提升文章质量还是有用的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad485077980, createdName=炼铁手, createdTime=Mon Sep 05 10:03:24 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126145, encodeId=e5e1212614526, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：是被踢出SCI了吗？文章逐年减少，4月了，现在文章才有32篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Sat Apr 15 22:41:13 CST 2023, time=2023-04-15, status=1, ipAttribution=浙江省)]

2021-10-21 Doctor Xu

审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2750.0
偏重的研究方向：肿瘤学;淋巴瘤
经验分享：投稿时间：18/Aug/2021
审稿返回：2021.9.13
接受：2021.10.15
On-line出版时间：21/Oct/2021

0 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211106, encodeId=3703221110668, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;慢病管理;肿瘤康复 经验分享：2023年度影响因子为2.5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:55:20 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2201206, encodeId=fdb722012064c, content=真的好慢啊，反复要原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d8514465, createdName=ms1000001446944017, createdTime=Tue Apr 30 10:08:27 CST 2024, time=2024-04-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2174772, encodeId=7da221e4772f9, content=记录一下： 23.11.27投稿 1A; 11.30 1ab; 12.02 1e; 12.06 收到邮件解释动物伦理问题并上传伦理批件； 12.08 1f; 12.11 又变成1e，收到邮件说提供WB原始图； 12.12 1f; 12.13 2a , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Wed Dec 13 18:07:24 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197766, encodeId=bca8219e766bf, content=跟共同作者联系不方便的慎投，经常要给每个作者发邮件，需要每个作者确认。而且3周了还在初审，找审稿人也巨慢，投另一个杂志ONCOtarget and therapy的时候经过一个半月没找到审稿人退回了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed Apr 10 15:59:10 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192990, encodeId=39982192990c9, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/47914c6997134a928ed954f7a8071140-N1SdjCB9k2Cx.jpg, createdBy=0fcc9212232, createdName=weichusci01, createdTime=Wed Mar 13 16:46:07 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1062688, encodeId=4040106268899, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2750.0 偏重的研究方向：肿瘤学;淋巴瘤 经验分享：投稿时间：18/Aug/2021 审稿返回：2021.9.13 接受：2021.10.15 On-line出版时间：21/Oct/2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8e32007663, createdName=Doctor Xu, createdTime=Thu Oct 21 20:20:00 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568257, encodeId=250856825e05, content=我的文章是用了一个多月的时间才找到审稿人。但是审稿速度很快，两周内意见就回来了？xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, beContent=xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab612479180, createdName=124544f0m58暂无昵称, createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161461, encodeId=c79f2161461d2, content=有1a持续16天还没消息的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Sun Oct 08 08:24:57 CST 2023, time=2023-10-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1243270, encodeId=668012432e0a6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;肝纤维化 经验分享：2022.1.26投稿，2022.1.31上传伦理，2022.2.3 1F，2022.2.8 1e，2022.2.9 1F，2022.2.9 2A，2022.2.27 2B，2022.3.10 2C，2022.3.21 2d，2022.3.29 2E，2022.3.30 2G，2022.4.11 3B，2022.4.19 4a，2022.8.18 4b, 2022.9.1 4C, 2022.9.4 5AB, 2022.9.5 5B。中间返修补实验的时间比较多，又碰上疫情反复，延长了2次返修时间，编辑人很好，返修回去后编辑因为一些文本问题多次让我修改，改到第4版才符合编辑要求；虽说中科院预警，但审稿人的意见还是很中肯，一个审稿人提了9个问题，另一个审稿人提了4个问题，4个问题短小精悍，对提升文章质量还是有用的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad485077980, createdName=炼铁手, createdTime=Mon Sep 05 10:03:24 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126145, encodeId=e5e1212614526, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：是被踢出SCI了吗？文章逐年减少，4月了，现在文章才有32篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Sat Apr 15 22:41:13 CST 2023, time=2023-04-15, status=1, ipAttribution=浙江省)]

2019-03-18 124544f0m58暂无昵称

我的文章是用了一个多月的时间才找到审稿人。但是审稿速度很快，两周内意见就回来了？xinqq1017 2019-03-18 00:00:00 发表:
一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？

xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？

186 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211106, encodeId=3703221110668, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;慢病管理;肿瘤康复 经验分享：2023年度影响因子为2.5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:55:20 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2201206, encodeId=fdb722012064c, content=真的好慢啊，反复要原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d8514465, createdName=ms1000001446944017, createdTime=Tue Apr 30 10:08:27 CST 2024, time=2024-04-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2174772, encodeId=7da221e4772f9, content=记录一下： 23.11.27投稿 1A; 11.30 1ab; 12.02 1e; 12.06 收到邮件解释动物伦理问题并上传伦理批件； 12.08 1f; 12.11 又变成1e，收到邮件说提供WB原始图； 12.12 1f; 12.13 2a , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Wed Dec 13 18:07:24 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197766, encodeId=bca8219e766bf, content=跟共同作者联系不方便的慎投，经常要给每个作者发邮件，需要每个作者确认。而且3周了还在初审，找审稿人也巨慢，投另一个杂志ONCOtarget and therapy的时候经过一个半月没找到审稿人退回了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed Apr 10 15:59:10 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192990, encodeId=39982192990c9, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/47914c6997134a928ed954f7a8071140-N1SdjCB9k2Cx.jpg, createdBy=0fcc9212232, createdName=weichusci01, createdTime=Wed Mar 13 16:46:07 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1062688, encodeId=4040106268899, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2750.0 偏重的研究方向：肿瘤学;淋巴瘤 经验分享：投稿时间：18/Aug/2021 审稿返回：2021.9.13 接受：2021.10.15 On-line出版时间：21/Oct/2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8e32007663, createdName=Doctor Xu, createdTime=Thu Oct 21 20:20:00 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568257, encodeId=250856825e05, content=我的文章是用了一个多月的时间才找到审稿人。但是审稿速度很快，两周内意见就回来了？xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, beContent=xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab612479180, createdName=124544f0m58暂无昵称, createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161461, encodeId=c79f2161461d2, content=有1a持续16天还没消息的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Sun Oct 08 08:24:57 CST 2023, time=2023-10-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1243270, encodeId=668012432e0a6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;肝纤维化 经验分享：2022.1.26投稿，2022.1.31上传伦理，2022.2.3 1F，2022.2.8 1e，2022.2.9 1F，2022.2.9 2A，2022.2.27 2B，2022.3.10 2C，2022.3.21 2d，2022.3.29 2E，2022.3.30 2G，2022.4.11 3B，2022.4.19 4a，2022.8.18 4b, 2022.9.1 4C, 2022.9.4 5AB, 2022.9.5 5B。中间返修补实验的时间比较多，又碰上疫情反复，延长了2次返修时间，编辑人很好，返修回去后编辑因为一些文本问题多次让我修改，改到第4版才符合编辑要求；虽说中科院预警，但审稿人的意见还是很中肯，一个审稿人提了9个问题，另一个审稿人提了4个问题，4个问题短小精悍，对提升文章质量还是有用的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad485077980, createdName=炼铁手, createdTime=Mon Sep 05 10:03:24 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126145, encodeId=e5e1212614526, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：是被踢出SCI了吗？文章逐年减少，4月了，现在文章才有32篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Sat Apr 15 22:41:13 CST 2023, time=2023-04-15, status=1, ipAttribution=浙江省)]

2023-10-08 ms7000000307422374 来自福建省

有1a持续16天还没消息的？

123 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211106, encodeId=3703221110668, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;慢病管理;肿瘤康复 经验分享：2023年度影响因子为2.5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:55:20 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2201206, encodeId=fdb722012064c, content=真的好慢啊，反复要原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d8514465, createdName=ms1000001446944017, createdTime=Tue Apr 30 10:08:27 CST 2024, time=2024-04-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2174772, encodeId=7da221e4772f9, content=记录一下： 23.11.27投稿 1A; 11.30 1ab; 12.02 1e; 12.06 收到邮件解释动物伦理问题并上传伦理批件； 12.08 1f; 12.11 又变成1e，收到邮件说提供WB原始图； 12.12 1f; 12.13 2a , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Wed Dec 13 18:07:24 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197766, encodeId=bca8219e766bf, content=跟共同作者联系不方便的慎投，经常要给每个作者发邮件，需要每个作者确认。而且3周了还在初审，找审稿人也巨慢，投另一个杂志ONCOtarget and therapy的时候经过一个半月没找到审稿人退回了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed Apr 10 15:59:10 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192990, encodeId=39982192990c9, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/47914c6997134a928ed954f7a8071140-N1SdjCB9k2Cx.jpg, createdBy=0fcc9212232, createdName=weichusci01, createdTime=Wed Mar 13 16:46:07 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1062688, encodeId=4040106268899, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2750.0 偏重的研究方向：肿瘤学;淋巴瘤 经验分享：投稿时间：18/Aug/2021 审稿返回：2021.9.13 接受：2021.10.15 On-line出版时间：21/Oct/2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8e32007663, createdName=Doctor Xu, createdTime=Thu Oct 21 20:20:00 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568257, encodeId=250856825e05, content=我的文章是用了一个多月的时间才找到审稿人。但是审稿速度很快，两周内意见就回来了？xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, beContent=xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab612479180, createdName=124544f0m58暂无昵称, createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161461, encodeId=c79f2161461d2, content=有1a持续16天还没消息的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Sun Oct 08 08:24:57 CST 2023, time=2023-10-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1243270, encodeId=668012432e0a6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;肝纤维化 经验分享：2022.1.26投稿，2022.1.31上传伦理，2022.2.3 1F，2022.2.8 1e，2022.2.9 1F，2022.2.9 2A，2022.2.27 2B，2022.3.10 2C，2022.3.21 2d，2022.3.29 2E，2022.3.30 2G，2022.4.11 3B，2022.4.19 4a，2022.8.18 4b, 2022.9.1 4C, 2022.9.4 5AB, 2022.9.5 5B。中间返修补实验的时间比较多，又碰上疫情反复，延长了2次返修时间，编辑人很好，返修回去后编辑因为一些文本问题多次让我修改，改到第4版才符合编辑要求；虽说中科院预警，但审稿人的意见还是很中肯，一个审稿人提了9个问题，另一个审稿人提了4个问题，4个问题短小精悍，对提升文章质量还是有用的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad485077980, createdName=炼铁手, createdTime=Mon Sep 05 10:03:24 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126145, encodeId=e5e1212614526, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：是被踢出SCI了吗？文章逐年减少，4月了，现在文章才有32篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Sat Apr 15 22:41:13 CST 2023, time=2023-04-15, status=1, ipAttribution=浙江省)]

2022-09-05 炼铁手

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;肝纤维化
经验分享：2022.1.26投稿，2022.1.31上传伦理，2022.2.3 1F，2022.2.8 1e，2022.2.9 1F，2022.2.9 2A，2022.2.27 2B，2022.3.10 2C，2022.3.21 2d，2022.3.29 2E，2022.3.30 2G，2022.4.11 3B，2022.4.19 4a，2022.8.18 4b, 2022.9.1 4C, 2022.9.4 5AB, 2022.9.5 5B。中间返修补实验的时间比较多，又碰上疫情反复，延长了2次返修时间，编辑人很好，返修回去后编辑因为一些文本问题多次让我修改，改到第4版才符合编辑要求；虽说中科院预警，但审稿人的意见还是很中肯，一个审稿人提了9个问题，另一个审稿人提了4个问题，4个问题短小精悍，对提升文章质量还是有用的

392 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211106, encodeId=3703221110668, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;慢病管理;肿瘤康复 经验分享：2023年度影响因子为2.5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:55:20 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2201206, encodeId=fdb722012064c, content=真的好慢啊，反复要原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d8514465, createdName=ms1000001446944017, createdTime=Tue Apr 30 10:08:27 CST 2024, time=2024-04-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2174772, encodeId=7da221e4772f9, content=记录一下： 23.11.27投稿 1A; 11.30 1ab; 12.02 1e; 12.06 收到邮件解释动物伦理问题并上传伦理批件； 12.08 1f; 12.11 又变成1e，收到邮件说提供WB原始图； 12.12 1f; 12.13 2a , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Wed Dec 13 18:07:24 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197766, encodeId=bca8219e766bf, content=跟共同作者联系不方便的慎投，经常要给每个作者发邮件，需要每个作者确认。而且3周了还在初审，找审稿人也巨慢，投另一个杂志ONCOtarget and therapy的时候经过一个半月没找到审稿人退回了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed Apr 10 15:59:10 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192990, encodeId=39982192990c9, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/47914c6997134a928ed954f7a8071140-N1SdjCB9k2Cx.jpg, createdBy=0fcc9212232, createdName=weichusci01, createdTime=Wed Mar 13 16:46:07 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1062688, encodeId=4040106268899, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2750.0 偏重的研究方向：肿瘤学;淋巴瘤 经验分享：投稿时间：18/Aug/2021 审稿返回：2021.9.13 接受：2021.10.15 On-line出版时间：21/Oct/2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8e32007663, createdName=Doctor Xu, createdTime=Thu Oct 21 20:20:00 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568257, encodeId=250856825e05, content=我的文章是用了一个多月的时间才找到审稿人。但是审稿速度很快，两周内意见就回来了？xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, beContent=xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab612479180, createdName=124544f0m58暂无昵称, createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161461, encodeId=c79f2161461d2, content=有1a持续16天还没消息的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Sun Oct 08 08:24:57 CST 2023, time=2023-10-08, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1243270, encodeId=668012432e0a6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;肝纤维化 经验分享：2022.1.26投稿，2022.1.31上传伦理，2022.2.3 1F，2022.2.8 1e，2022.2.9 1F，2022.2.9 2A，2022.2.27 2B，2022.3.10 2C，2022.3.21 2d，2022.3.29 2E，2022.3.30 2G，2022.4.11 3B，2022.4.19 4a，2022.8.18 4b, 2022.9.1 4C, 2022.9.4 5AB, 2022.9.5 5B。中间返修补实验的时间比较多，又碰上疫情反复，延长了2次返修时间，编辑人很好，返修回去后编辑因为一些文本问题多次让我修改，改到第4版才符合编辑要求；虽说中科院预警，但审稿人的意见还是很中肯，一个审稿人提了9个问题，另一个审稿人提了4个问题，4个问题短小精悍，对提升文章质量还是有用的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=392, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad485077980, createdName=炼铁手, createdTime=Mon Sep 05 10:03:24 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2126145, encodeId=e5e1212614526, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：是被踢出SCI了吗？文章逐年减少，4月了，现在文章才有32篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=291, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Sat Apr 15 22:41:13 CST 2023, time=2023-04-15, status=1, ipAttribution=浙江省)]

2023-04-15 左手摸机来自浙江省

审稿速度:2.0 | 投稿命中率:75.0
经验分享：是被踢出SCI了吗？文章逐年减少，4月了，现在文章才有32篇

291 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务